Hyperphosphatemic tumoral calcinosis caused by FGF23 compound heterozygous mutations: what are the therapeutic options for a better control of phosphatemia? https://t.co/pmRmZRMQ2s
RT @Ped_Neph: 🆓🔓 Free access for limited time as part of @ClinMedJournals 'Influential Pediatrics' portfolio. Hyperphosphatemic tumoral ca…
🆓🔓 Free access for limited time as part of @ClinMedJournals 'Influential Pediatrics' portfolio. Hyperphosphatemic tumoral calcinosis caused by FGF23 compound heterozygous mutations: what are the therapeutic options for a better control of phosphatemia? ht
RT @Ped_Neph: 🆕 Hyperphosphatemic tumoral calcinosis caused by FGF23 compound heterozygous mutations: what are the therapeutic options for…
🆕 Hyperphosphatemic tumoral calcinosis caused by FGF23 compound heterozygous mutations: what are the therapeutic options for a better control of phosphatemia? https://t.co/CwiEVBKqCA Shareable link: https://t.co/ErCZhw74GB @CHUdeLyon @UnivLyon1 @APHP @Ins